Xcel Brands, Paradium.AI partner to launch PetHelpful x Cesar Millan co-brand in 2027
Bitget2026/10/08 12:02Xcel Brands entered a deal with Paradium.AI to launch PetHelpful x Trust·Respect·Love by Cesar Millan, with retail debut slated for Q3 2027. Co-brand targets multiple pet categories, with Xcel using licensed operating partners to develop and manufacture the product line. Paradium will use its Cutter Studios AI to turn long-form video into shoppable short videos, supporting always-on commerce content. Combined distribution footprint cited at more than 50 million, including 21 million social followers and 31 million monthly readers. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XCel Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080800PRIMZONEFULLFEED9841651) on October 08, 2026, and is solely responsible for the information contained therein.
- Xcel Brands entered a deal with Paradium.AI to launch PetHelpful x Trust·Respect·Love by Cesar Millan, with retail debut slated for Q3 2027.
- Co-brand targets multiple pet categories, with Xcel using licensed operating partners to develop and manufacture the product line.
- Paradium will use its Cutter Studios AI to turn long-form video into shoppable short videos, supporting always-on commerce content.
- Combined distribution footprint cited at more than 50 million, including 21 million social followers and 31 million monthly readers.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
